Protalix BioTherapeutics, Inc. Common Stock (PLX) Stock Price, Quote & AI Analysis
Live PLX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Protalix BioTherapeutics, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Protalix BioTherapeutics, Inc. Common Stock (PLX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Protalix BioTherapeutics, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Protalix BioTherapeutics, Inc. Common Stock Overview
Company information
Company Overview
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Protalix BioTherapeutics, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...